International Myeloma Foundation's New Chapter with Heather Cooper Ortner
The International Myeloma Foundation (IMF) has officially announced the appointment of Heather Cooper Ortner as its new President and Chief Executive Officer. Her extensive background in non-profit leadership and deep association with the IMF positions her uniquely to lead the organization forward.
A Welcoming Return
Heather's professional journey includes significant roles at organizations like Alzheimer's Los Angeles and the Dr. Susan Love Research Foundation. This experience has not only equipped her with valuable insights but has fostered a strong commitment to improving the lives of those affected by myeloma. She is excited about her return to the IMF, stating that it feels like a full-circle moment.
Experience Driving Change
Heather has been with the IMF for seven pivotal years, during which she served as Executive Vice President of Development. Her knowledge of the organization’s mission and her leadership in various health-related non-profits enable her to step right into this role with confidence. She expresses a desire to work collaboratively with the IMF's Board of Directors, dedicated staff, and the extensive community of volunteers worldwide to advance their collective mission.
Visionary Leadership Acknowledged
Andy Kuzneski III, chair of the IMF Board's search committee, emphasized the thorough selection process that led to Heather's appointment. After evaluating many candidates, Heather was chosen because of her innovative leadership and deep-rooted connection to the IMF's mission. This confidence in her capabilities showcases that the IMF values experience and dedication in leadership as they move into a new era.
Commitment to Advocacy and Research
IMF has a strong commitment to research, education, support, and advocacy for myeloma patients. With Heather at the helm, the organization is poised to elevate these initiatives even further. Her strategic vision aims to enhance education efforts, improve patient advocacy, and advance research on myeloma’s treatment options.
The Importance of Community Engagement
Heather’s statement about the necessity for urgency and determination resonates with all stakeholders involved. She passionately looks forward to working with various dedicated groups and individuals who play pivotal roles in bettering the lives of myeloma patients and their families. Together, they will aim to enhance resources and expand awareness for this disease.
A Historical Moment for the IMF
The IMF is entering a significant milestone, celebrating its 35th anniversary. This ongoing celebration of dedication to the myeloma community brings immense importance to Heather's appointment, aligning perfectly with the organization’s aspirations for future advancements in patient care and research initiatives.
Building on a Solid Legacy
Ms. Cooper Ortner's past achievements confirm her skill set, making her an ideal candidate for the President and CEO role. Her previous activities in non-profit leadership showcase her ability to manage and innovate within the space effectively. Being recognized by key figures within the organization indicates a unanimously positive outlook on her leadership.
Looking Forward to Innovation and Growth
As Heather begins her journey with the IMF, the focus will be on continuing to improve the quality of life for myeloma patients. The organization’s mission drives a shared vision of hope, promising that no patient has to navigate the challenges of this disease alone. Through Heather's leadership, the IMF plans to explore new educational avenues and increase research partnerships globally.
Frequently Asked Questions
Who is Heather Cooper Ortner?
Heather Cooper Ortner is the new President & CEO of the International Myeloma Foundation, with extensive experience in nonprofit leadership.
What previous roles has Heather held?
Heather has been the President & CEO of Alzheimer's Los Angeles and the former CEO of the Dr. Susan Love Research Foundation.
What is the mission of the International Myeloma Foundation?
The IMF aims to improve the quality of life of myeloma patients through research, education, support, and advocacy.
Why is Heather's return significant for the IMF?
Her return is significant as she has deep roots in the organization, bringing valuable leadership and vision for further growth.
How does the IMF plan to celebrate its 35th anniversary?
The IMF will celebrate its 35th anniversary by focusing on advancing research and enhancing patient support initiatives under new leadership.
